शेयर मूल्य

तारीख	Shanghai Fosun Pharmaceutical Group Co शेयर मूल्य
13/9/2024	22.22 undefined
12/9/2024	22.39 undefined
11/9/2024	22.50 undefined
10/9/2024	22.35 undefined
9/9/2024	22.34 undefined
6/9/2024	22.51 undefined
5/9/2024	22.82 undefined
4/9/2024	22.55 undefined
3/9/2024	22.70 undefined
2/9/2024	22.38 undefined
30/8/2024	22.54 undefined
29/8/2024	22.68 undefined
28/8/2024	22.36 undefined
27/8/2024	22.30 undefined
26/8/2024	22.34 undefined
23/8/2024	22.40 undefined
22/8/2024	22.39 undefined
21/8/2024	22.77 undefined
20/8/2024	23.06 undefined
19/8/2024	23.29 undefined
16/8/2024	23.45 undefined

तारीख	Shanghai Fosun Pharmaceutical Group Co राजस्व	Shanghai Fosun Pharmaceutical Group Co EBIT	Shanghai Fosun Pharmaceutical Group Co लाभ
2026e	51.85 अरब undefined	2.79 अरब undefined	3.78 अरब undefined
2025e	48.53 अरब undefined	2.63 अरब undefined	3.32 अरब undefined
2024e	44.88 अरब undefined	2.26 अरब undefined	2.82 अरब undefined
2023	41.4 अरब undefined	1.29 अरब undefined	2.39 अरब undefined
2022	43.95 अरब undefined	3.5 अरब undefined	3.73 अरब undefined
2021	39.01 अरब undefined	2.55 अरब undefined	4.74 अरब undefined
2020	30.31 अरब undefined	2.64 अरब undefined	3.66 अरब undefined
2019	28.59 अरब undefined	2.49 अरब undefined	3.32 अरब undefined
2018	24.92 अरब undefined	2.29 अरब undefined	2.71 अरब undefined
2017	18.53 अरब undefined	2.24 अरब undefined	3.12 अरब undefined
2016	14.63 अरब undefined	1.64 अरब undefined	2.81 अरब undefined
2015	12.61 अरब undefined	1.36 अरब undefined	2.46 अरब undefined
2014	12.03 अरब undefined	1.11 अरब undefined	2.11 अरब undefined
2013	10 अरब undefined	1.03 अरब undefined	1.58 अरब undefined
2012	7.34 अरब undefined	553 मिलियन undefined	1.56 अरब undefined
2011	6.49 अरब undefined	324 मिलियन undefined	1.17 अरब undefined
2010	4.56 अरब undefined	163 मिलियन undefined	864 मिलियन undefined
2009	3.87 अरब undefined	157 मिलियन undefined	2.5 अरब undefined
2008	3.77 अरब undefined	118 मिलियन undefined	691 मिलियन undefined
2007	3.69 अरब undefined	164 मिलियन undefined	626 मिलियन undefined
2006	4.08 अरब undefined	92 मिलियन undefined	258 मिलियन undefined
2005	2.99 अरब undefined	143 मिलियन undefined	159 मिलियन undefined
2004	2.43 अरब undefined	153 मिलियन undefined	215 मिलियन undefined

	राजस्व	EBIT	लाभ
2004	2.43 अरब CNY	153 मिलियन CNY	215 मिलियन CNY
2005	2.99 अरब CNY	143 मिलियन CNY	159 मिलियन CNY
2006	4.08 अरब CNY	92 मिलियन CNY	258 मिलियन CNY
2007	3.69 अरब CNY	164 मिलियन CNY	626 मिलियन CNY
2008	3.77 अरब CNY	118 मिलियन CNY	691 मिलियन CNY
2009	3.87 अरब CNY	157 मिलियन CNY	2.5 अरब CNY
2010	4.56 अरब CNY	163 मिलियन CNY	864 मिलियन CNY
2011	6.49 अरब CNY	324 मिलियन CNY	1.17 अरब CNY
2012	7.34 अरब CNY	553 मिलियन CNY	1.56 अरब CNY
2013	10 अरब CNY	1.03 अरब CNY	1.58 अरब CNY
2014	12.03 अरब CNY	1.11 अरब CNY	2.11 अरब CNY
2015	12.61 अरब CNY	1.36 अरब CNY	2.46 अरब CNY
2016	14.63 अरब CNY	1.64 अरब CNY	2.81 अरब CNY
2017	18.53 अरब CNY	2.24 अरब CNY	3.12 अरब CNY
2018	24.92 अरब CNY	2.29 अरब CNY	2.71 अरब CNY
2019	28.59 अरब CNY	2.49 अरब CNY	3.32 अरब CNY
2020	30.31 अरब CNY	2.64 अरब CNY	3.66 अरब CNY
2021	39.01 अरब CNY	2.55 अरब CNY	4.74 अरब CNY
2022	43.95 अरब CNY	3.5 अरब CNY	3.73 अरब CNY
2023	41.4 अरब CNY	1.29 अरब CNY	2.39 अरब CNY
2024e	44.88 अरब CNY	2.26 अरब CNY	2.82 अरब CNY
2025e	48.53 अरब CNY	2.63 अरब CNY	3.32 अरब CNY
2026e	51.85 अरब CNY	2.79 अरब CNY	3.78 अरब CNY

Shanghai Fosun Pharmaceutical Group Co सकल मार्जिन	Shanghai Fosun Pharmaceutical Group Co लाभ मार्जिन	Shanghai Fosun Pharmaceutical Group Co EBIT मार्जिन	Shanghai Fosun Pharmaceutical Group Co लाभ मार्जिन
2026e	47.54 %	5.37 %	7.3 %
2025e	47.54 %	5.42 %	6.84 %
2024e	47.54 %	5.04 %	6.29 %
2023	47.54 %	3.11 %	5.76 %
2022	47.09 %	7.97 %	8.49 %
2021	47.97 %	6.54 %	12.14 %
2020	55.47 %	8.72 %	12.09 %
2019	59.57 %	8.71 %	11.62 %
2018	58.34 %	9.17 %	10.87 %
2017	58.84 %	12.06 %	16.86 %
2016	53.81 %	11.23 %	19.18 %
2015	49.78 %	10.81 %	19.51 %
2014	43.87 %	9.19 %	17.57 %
2013	44.22 %	10.3 %	15.84 %
2012	43.62 %	7.53 %	21.31 %
2011	37.63 %	5 %	17.98 %
2010	33.9 %	3.58 %	18.97 %
2009	32.02 %	4.05 %	64.51 %
2008	27.67 %	3.13 %	18.31 %
2007	26.59 %	4.44 %	16.95 %
2006	21.34 %	2.25 %	6.32 %
2005	29.98 %	4.78 %	5.32 %
2004	31.22 %	6.31 %	8.87 %

	सकल मार्जिन	EBIT मार्जिन	लाभ मार्जिन
2004	31.22 %	6.31 %	8.87 %
2005	29.98 %	4.78 %	5.32 %
2006	21.34 %	2.25 %	6.32 %
2007	26.59 %	4.44 %	16.95 %
2008	27.67 %	3.13 %	18.31 %
2009	32.02 %	4.05 %	64.51 %
2010	33.9 %	3.58 %	18.97 %
2011	37.63 %	5 %	17.98 %
2012	43.62 %	7.53 %	21.31 %
2013	44.22 %	10.3 %	15.84 %
2014	43.87 %	9.19 %	17.57 %
2015	49.78 %	10.81 %	19.51 %
2016	53.81 %	11.23 %	19.18 %
2017	58.84 %	12.06 %	16.86 %
2018	58.34 %	9.17 %	10.87 %
2019	59.57 %	8.71 %	11.62 %
2020	55.47 %	8.72 %	12.09 %
2021	47.97 %	6.54 %	12.14 %
2022	47.09 %	7.97 %	8.49 %
2023	47.54 %	3.11 %	5.76 %
2024e	47.54 %	5.04 %	6.29 %
2025e	47.54 %	5.42 %	6.84 %
2026e	47.54 %	5.37 %	7.3 %

तारीख	Shanghai Fosun Pharmaceutical Group Co प्रति शेयर बिक्री	Shanghai Fosun Pharmaceutical Group Co EBIT प्रति शेयर	Shanghai Fosun Pharmaceutical Group Co प्रति शेयर लाभ
2026e	24.5 undefined	0 undefined	1.79 undefined
2025e	22.93 undefined	0 undefined	1.57 undefined
2024e	21.21 undefined	0 undefined	1.33 undefined
2023	15.51 undefined	0.48 undefined	0.89 undefined
2022	16.86 undefined	1.34 undefined	1.43 undefined
2021	15.22 undefined	1 undefined	1.85 undefined
2020	11.82 undefined	1.03 undefined	1.43 undefined
2019	11.15 undefined	0.97 undefined	1.3 undefined
2018	9.88 undefined	0.91 undefined	1.07 undefined
2017	7.53 undefined	0.91 undefined	1.27 undefined
2016	6.28 undefined	0.71 undefined	1.2 undefined
2015	5.43 undefined	0.59 undefined	1.06 undefined
2014	5.24 undefined	0.48 undefined	0.92 undefined
2013	4.46 undefined	0.46 undefined	0.71 undefined
2012	3.28 undefined	0.25 undefined	0.7 undefined
2011	3.41 undefined	0.17 undefined	0.61 undefined
2010	2.42 undefined	0.09 undefined	0.46 undefined
2009	2.09 undefined	0.08 undefined	1.35 undefined
2008	2.03 undefined	0.06 undefined	0.37 undefined
2007	1.99 undefined	0.09 undefined	0.34 undefined
2006	2.2 undefined	0.05 undefined	0.14 undefined
2005	1.84 undefined	0.09 undefined	0.1 undefined
2004	1.5 undefined	0.09 undefined	0.13 undefined

	प्रति शेयर बिक्री	EBIT प्रति शेयर	प्रति शेयर लाभ
2004	1.5 CNY	0.09 CNY	0.13 CNY
2005	1.84 CNY	0.09 CNY	0.1 CNY
2006	2.2 CNY	0.05 CNY	0.14 CNY
2007	1.99 CNY	0.09 CNY	0.34 CNY
2008	2.03 CNY	0.06 CNY	0.37 CNY
2009	2.09 CNY	0.08 CNY	1.35 CNY
2010	2.42 CNY	0.09 CNY	0.46 CNY
2011	3.41 CNY	0.17 CNY	0.61 CNY
2012	3.28 CNY	0.25 CNY	0.7 CNY
2013	4.46 CNY	0.46 CNY	0.71 CNY
2014	5.24 CNY	0.48 CNY	0.92 CNY
2015	5.43 CNY	0.59 CNY	1.06 CNY
2016	6.28 CNY	0.71 CNY	1.2 CNY
2017	7.53 CNY	0.91 CNY	1.27 CNY
2018	9.88 CNY	0.91 CNY	1.07 CNY
2019	11.15 CNY	0.97 CNY	1.3 CNY
2020	11.82 CNY	1.03 CNY	1.43 CNY
2021	15.22 CNY	1 CNY	1.85 CNY
2022	16.86 CNY	1.34 CNY	1.43 CNY
2023	15.51 CNY	0.48 CNY	0.89 CNY
2024e	21.21 CNY	0 CNY	1.33 CNY
2025e	22.93 CNY	0 CNY	1.57 CNY
2026e	24.5 CNY	0 CNY	1.79 CNY

	अंश की संख्या
2004	1.61 अरब Aktien
2005	1.62 अरब Aktien
2006	1.86 अरब Aktien
2007	1.86 अरब Aktien
2008	1.86 अरब Aktien
2009	1.86 अरब Aktien
2010	1.89 अरब Aktien
2011	1.9 अरब Aktien
2012	2.24 अरब Aktien
2013	2.24 अरब Aktien
2014	2.3 अरब Aktien
2015	2.32 अरब Aktien
2016	2.33 अरब Aktien
2017	2.46 अरब Aktien
2018	2.52 अरब Aktien
2019	2.56 अरब Aktien
2020	2.56 अरब Aktien
2021	2.56 अरब Aktien
2022	2.61 अरब Aktien
2023	2.67 अरब Aktien
2024e	2.67 अरब Aktien
2025e	2.67 अरब Aktien
2026e	2.67 अरब Aktien

तारीख	Shanghai Fosun Pharmaceutical Group Co लाभांश
2026e	0.44 undefined
2025e	0.44 undefined
2024e	0.44 undefined
2023	0.42 undefined
2022	0.56 undefined
2021	0.43 undefined
2020	0.39 undefined
2019	0.32 undefined
2018	0.38 undefined
2017	0.35 undefined
2016	0.32 undefined
2015	0.28 undefined
2014	0.27 undefined
2013	0.21 undefined
2012	0.1 undefined
2011	0.1 undefined
2010	0.07 undefined
2009	0.07 undefined
2008	0.07 undefined
2007	0.05 undefined
2006	0.17 undefined
2005	0.08 undefined
2004	0.1 undefined

	लाभांश	डिविडेंड (अनुमान)
2004	0.1 CNY	0 CNY
2005	0.08 CNY	0 CNY
2006	0.17 CNY	0 CNY
2007	0.05 CNY	0 CNY
2008	0.07 CNY	0 CNY
2009	0.07 CNY	0 CNY
2010	0.07 CNY	0 CNY
2011	0.1 CNY	0 CNY
2012	0.1 CNY	0 CNY
2013	0.21 CNY	0 CNY
2014	0.27 CNY	0 CNY
2015	0.28 CNY	0 CNY
2016	0.32 CNY	0 CNY
2017	0.35 CNY	0 CNY
2018	0.38 CNY	0 CNY
2019	0.32 CNY	0 CNY
2020	0.39 CNY	0 CNY
2021	0.43 CNY	0 CNY
2022	0.56 CNY	0 CNY
2023	0.42 CNY	0 CNY
2024e	0 CNY	0.44 CNY
2025e	0 CNY	0.44 CNY
2026e	0 CNY	0.44 CNY

तारीख	Shanghai Fosun Pharmaceutical Group Co वितरण अनुपात
2026e	31.31 %
2025e	33.27 %
2024e	30.77 %
2023	29.89 %
2022	39.14 %
2021	23.27 %
2020	27.27 %
2019	24.62 %
2018	35.51 %
2017	27.56 %
2016	26.67 %
2015	26.42 %
2014	29.35 %
2013	29.58 %
2012	14.29 %
2011	16.39 %
2010	14.49 %
2009	4.94 %
2008	18.02 %
2007	15.08 %
2006	124.54 %
2005	76.92 %
2004	78.9 %

	वितरण अनुपात
2004	78.9 %
2005	76.92 %
2006	124.54 %
2007	15.08 %
2008	18.02 %
2009	4.94 %
2010	14.49 %
2011	16.39 %
2012	14.29 %
2013	29.58 %
2014	29.35 %
2015	26.42 %
2016	26.67 %
2017	27.56 %
2018	35.51 %
2019	24.62 %
2020	27.27 %
2021	23.27 %
2022	39.14 %
2023	29.89 %
2024e	30.77 %
2025e	33.27 %
2026e	31.31 %

तिथि	EPS-अनुमान	वास्तविक EPS	रिपोर्टिंग तिमाही
30/6/2024	0.28	0.23 (-18.67 %)	2024 Q2
31/3/2024	0.35	0.23 (-34 %)	2024 Q1
31/12/2023	0.41	0.04 (-90.22 %)	2023 Q4
30/9/2023	0.39	0.19 (-52.79 %)	2023 Q3
30/6/2023	0.33	0.3 (-8.62 %)	2023 Q2
31/3/2023	0.38	0.37 (-3.6 %)	2023 Q1
31/12/2022	0.38	0.48 (26.72 %)	2022 Q4
30/9/2022	0.41	0.34 (-16.89 %)	2022 Q3
30/6/2022	0.43	0.42 (-2.17 %)	2022 Q2
31/3/2022	0.37	0.18 (-51.83 %)	2022 Q1
31/12/2021	0.34	0.46 (33.95 %)	2021 Q4
30/9/2021	0.47	0.42 (-11.52 %)	2021 Q3
30/6/2021	0.96	0.33 (-65.61 %)	2021 Q2
31/3/2021	0.34	0.33 (-3.9 %)	2021 Q1
31/12/2020	0.44	0.46 (3.51 %)	2020 Q4
30/9/2020	0.31	0.3 (-4.18 %)	2020 Q3
30/6/2020	0.36	0.44 (22.7 %)	2020 Q2
31/3/2020	0.22	0.23 (6.73 %)	2020 Q1
31/12/2019	0.63	0.49 (-22.58 %)	2019 Q4
30/9/2019	0.29	0.22 (-23.58 %)	2019 Q3
30/6/2019	0.35	0.31 (-11.28 %)	2019 Q2
31/3/2019	0.33	0.28 (-14.71 %)	2019 Q1
31/12/2018	0.27	0.24 (-11.99 %)	2018 Q4
30/9/2018	0.35	0.2 (-43.42 %)	2018 Q3
30/6/2018	0.4	0.35 (-13.37 %)	2018 Q2
31/3/2018	0.33	0.28 (-15.99 %)	2018 Q1
31/12/2017	0.32	0.28 (-13.06 %)	2017 Q4
30/9/2017	0.31	0.29 (-7.53 %)	2017 Q3
30/6/2017	0.41	0.39 (-4.53 %)	2017 Q2
31/3/2017	0.31	0.31 (0.62 %)	2017 Q1
31/12/2016	0.29	0.26 (-11.23 %)	2016 Q4
30/9/2016	0.31	0.29 (-5.35 %)	2016 Q3
30/6/2016	0.35	0.37 (5.87 %)	2016 Q2
31/3/2016	0.28	0.27 (-4.53 %)	2016 Q1
31/12/2015	0.28	0.24 (-13.61 %)	2015 Q4
30/9/2015	0.3	0.25 (-17.49 %)	2015 Q3
30/6/2015	0.28	0.33 (16.69 %)	2015 Q2
31/3/2015	0.24	0.23 (-5.12 %)	2015 Q1
31/12/2014	0.28	0.23 (-19.1 %)	2014 Q4
30/9/2014	0.29	0.24 (-16.03 %)	2014 Q3
30/6/2014	0.34	0.25 (-25.04 %)	2014 Q2
31/12/2011	0.09	0.05 (-44.88 %)	2011 Q4

%	नाम	शेयर	परिवर्तन	तारीख
41.87609 %	Shanghai Fosun High Technology (Group) Co., Ltd.	88,63,15,955	0	31/12/2023
1.13897 %	China Merchants Fund Management Co. Ltd.	2,41,06,618	-8,18,400	31/12/2023
0.86884 %	E Fund Management Co. Ltd.	1,83,89,093	-5,71,853	31/12/2023
0.54509 %	Yinhua Fund Management Co., Ltd.	1,15,37,035	10,20,740	31/12/2023
0.44269 %	Huatai-PineBridge Fund Management Co., Ltd.	93,69,625	12,12,600	31/12/2023
0.41219 %	China Universal Asset Management Co., Ltd.	87,24,081	-8,35,598	31/12/2023
0.37310 %	Yunnan Qijia Investment Co., Ltd.	78,96,749	0	31/12/2023
0.37167 %	Tianhong Asset Management Co., Ltd.	78,66,489	0	31/12/2023
0.34830 %	GF Fund Management Co., Ltd.	73,71,877	-1,100	31/12/2023
0.29118 %	CITIC Securities Co., Ltd. (Asset Management)	61,62,837	61,62,837	31/12/2023
0.19834 %	The Vanguard Group, Inc.	41,97,813	-2,81,800	31/3/2024
0.16882 %	BlackRock Institutional Trust Company, N.A.	35,73,033	-39,000	31/3/2024
0.13358 %	Harvest Fund Management Co., Ltd.	28,27,232	0	29/2/2024
0.12730 %	HuaAn Fund Management Co., Ltd.	26,94,281	22,900	31/12/2023
0.11661 %	BlackRock Advisors (UK) Limited	24,68,160	74,000	31/3/2024
0.10666 %	Penghua Fund Management Co., Ltd.	22,57,391	20,26,300	30/6/2023
0.08002 %	Hwabao WP Fund Management Co., Ltd.	16,93,700	16,39,900	30/6/2023
0.07096 %	Fullgoal Fund Management Co., Ltd.	15,01,846	15,400	31/12/2023
0.06525 %	Norges Bank Investment Management (NBIM)	13,80,948	-24,27,756	31/12/2023
0.06521 %	Wu (Yifang)	13,80,100	0	31/12/2023
0.05419 %	Guotai Asset Management Co., Ltd.	11,46,860	82,100	31/12/2023
0.04884 %	Harvest Global Investments Limited	10,33,814	0	31/3/2024
0.04845 %	Galaxy Asset Management Co., Ltd.	10,25,484	-1,200	31/12/2023
0.04825 %	China Southern Asset Management Co. Ltd.	10,21,224	-5,800	31/12/2023
0.04022 %	China Asset Management (Hong Kong) Limited	8,51,340	65,600	31/3/2024
0.03847 %	Fortune & Royal Asset Management Company Limited	8,14,200	1,65,000	30/6/2023
0.03639 %	ICBC Credit Suisse Asset Management Co. Ltd.	7,70,131	2,52,500	30/6/2023
0.03444 %	DWS Investments UK Limited	7,28,976	-549	31/3/2024
0.03365 %	Amundi Asset Management, SAS	7,12,160	1,81,060	31/3/2024
0.02740 %	Essence Fund Management Co., Ltd.	5,80,002	1,500	31/12/2023
0.02596 %	SWS MU Fund Management Co., Ltd.	5,49,552	-9,004	31/12/2023
0.02356 %	Handelsbanken Kapitalförvaltning AB	4,98,700	0	31/3/2024
0.02352 %	CITIC Prudential Fund Management Co., Ltd.	4,97,835	-1,400	31/12/2023
0.02210 %	Wang (Ke Xin)	4,67,700	0	31/12/2023
0.02165 %	Yao (Fang)	4,58,300	0	31/12/2023
0.02035 %	CCB Principal Asset Management Co., Ltd.	4,30,646	-3,400	31/12/2023
0.02020 %	Mellon Investments Corporation	4,27,577	-77,300	31/3/2024
0.02017 %	State Street Global Advisors (US)	4,26,982	-12,500	31/3/2024
0.01975 %	Guan (Xiao Hui)	4,18,100	0	31/12/2023
0.01745 %	BlackRock (Singapore) Limited	3,69,335	79,900	31/3/2024
0.01599 %	Taikang Asset Management Co., Ltd.	3,38,405	-3,800	30/6/2023
0.01582 %	Geode Capital Management, L.L.C.	3,34,800	5,700	29/2/2024
0.01482 %	Aviva Investors Global Services Limited	3,13,721	1,07,544	29/2/2024
0.01352 %	Bosera Asset Management Co., Ltd.	2,86,200	98,357	31/12/2023
0.01322 %	Tibet Eastmoney Fund Management Co., Ltd.	2,79,700	-26,600	31/12/2023
0.01290 %	JPMorgan Asset Management (China) Company Limited.	2,73,000	23,500	30/6/2023
0.01240 %	California State Teachers Retirement System	2,62,400	84,800	30/6/2023
0.01235 %	State Street Global Advisors (UK) Ltd.	2,61,367	1	31/3/2024
0.01176 %	UBS Asset Management (UK) Ltd.	2,48,800	300	31/3/2024
0.01095 %	Credit Suisse Funds AG	2,31,712	-2,100	31/3/2024
0.01073 %	Wen (Deyong)	2,27,100	0	31/12/2023
0.00981 %	China Life AMP Asset Management Co., Ltd	2,07,600	17,500	31/12/2023
0.00883 %	Krane Funds Advisors, LLC	1,86,929	4,600	31/3/2024
0.00869 %	Nuveen LLC	1,83,988	0	31/3/2024
0.00841 %	Northern Trust Global Investments Limited	1,78,000	0	29/2/2024
0.00768 %	BlackRock Investment Management (UK) Ltd.	1,62,500	0	29/2/2024
0.00762 %	Charles Schwab Investment Management, Inc.	1,61,200	0	31/3/2024
0.00759 %	Amundi Japan Ltd.	1,60,600	3,300	31/3/2024
0.00733 %	DWS Investment GmbH	1,55,075	-3,600	31/3/2024
0.00728 %	Chen (Yu Qing)	1,54,000	0	31/12/2023
0.00678 %	Florida State Board of Administration	1,43,600	93,000	30/9/2022
0.00673 %	Nuode Asset Management Company Limited	1,42,500	23,900	30/6/2023
0.00670 %	Changsheng Fund Management Co., Ltd.	1,41,864	-4,500	31/12/2023
0.00655 %	CPIC Fund Management Co., Ltd.	1,38,654	-1,000	31/12/2023
0.00636 %	Fubon Asset Management Company Ltd.	1,34,545	-12,300	29/2/2024
0.00618 %	HSBC Global Asset Management (UK) Limited	1,30,882	200	29/2/2024
0.00595 %	First Seafront Fund Management Co., Ltd.	1,25,951	0	31/12/2023
0.00595 %	Huashang Fund Management Co., Ltd.	1,25,900	-6,58,300	30/6/2023
0.00572 %	Hony Horizon Fund Management Co., Ltd.	1,21,000	2,700	30/6/2023
0.00544 %	LBP AM	1,15,160	36,105	29/2/2024
0.00540 %	UBS Asset Management (Switzerland)	1,14,200	0	29/2/2024
0.00539 %	Chen (Qi Yu)	1,14,075	0	31/12/2023
0.00536 %	Feng (Rongli)	1,13,500	0	31/12/2023
0.00536 %	Wang (Donghua)	1,13,500	0	31/12/2023
0.00536 %	Li (Jing)	1,13,500	0	31/12/2023
0.00523 %	Caitong Fund Management Co., Ltd.	1,10,700	28,300	30/6/2023
0.00520 %	PGGM Vermogensbeheer B.V.	1,10,010	-357	31/7/2023
0.00488 %	Mercer Global Investments Management Ltd	1,03,200	0	31/3/2024
0.00471 %	Pictet Asset Management Ltd.	99,600	-5,400	31/12/2023
0.00459 %	Cardano Asset Management NV	97,176	97,176	29/2/2024
0.00423 %	BOCI-Prudential Asset Management Ltd.	89,500	900	29/2/2024
0.00399 %	ABC-CA Fund Management Co., Ltd.	84,442	-400	31/12/2023
0.00393 %	Franklin Templeton Sealand Fund Management Co., Ltd.	83,200	83,172	30/6/2023
0.00386 %	Dong (Xiao Xian)	81,800	0	31/12/2023
0.00379 %	Mei (Jing Ping)	80,300	0	31/12/2023
0.00372 %	Mirae Asset Global Investments Co., Ltd.	78,704	334	31/1/2024
0.00366 %	Wanjia Asset Management Co., Ltd.	77,549	-2,500	31/12/2023
0.00335 %	Founder Fubon Fund Management Co., Ltd.	70,900	-3,54,100	30/6/2023
0.00335 %	Legal & General Investment Management Ltd.	70,900	-14,000	29/2/2024
0.00332 %	CICC Fund Management Co Ltd.	70,300	5,400	31/12/2023
0.00332 %	Xu (Aihua)	70,200	0	31/12/2023
0.00316 %	Li (Dongjiu)	66,800	46,800	31/12/2023
0.00316 %	Liu (Yi)	66,800	0	31/12/2023
0.00316 %	Bao (Qingui)	66,800	0	31/12/2023
0.00312 %	Minsheng Royal Fund Management Company Ltd.	65,943	-6,700	30/6/2023
0.00305 %	PICC Asset Management Company Limited	64,500	24,200	30/6/2023
0.00273 %	Manulife Fund Management Co., Ltd.	57,700	36,200	30/6/2023
0.00268 %	Zhu (Yue)	56,800	0	31/12/2023
0.00255 %	Hang Seng Investment Management Ltd.	53,975	-622	31/3/2024
0.00236 %	Nykredit Bank AS	49,901	36,501	29/2/2024

What values and corporate philosophy does Shanghai Fosun Pharmaceutical Group Co represent?

Shanghai Fosun Pharmaceutical Group Co Ltd represents a set of core values and a strong corporate philosophy. With a focus on innovation, integrity, and social responsibility, the company strives to deliver high-quality pharmaceutical products and healthcare services. Shanghai Fosun Pharmaceutical Group Co Ltd believes in fostering sustainable development and prioritizes the well-being of patients and the community. The company's dedication to excellence, patient-centric approach, and continuous research and development efforts make it a prominent player in the pharmaceutical industry. Shanghai Fosun Pharmaceutical Group Co Ltd exemplifies a commitment to quality, ethical practices, and making a positive impact on society.

In which countries and regions is Shanghai Fosun Pharmaceutical Group Co primarily present?

The Shanghai Fosun Pharmaceutical Group Co Ltd primarily operates and has a significant presence in multiple countries and regions. The company is mainly active in China, where its headquarters is located. It also has a strong presence in various other regions and countries, including the United States, Europe, India, and Africa. Shanghai Fosun Pharmaceutical Group Co Ltd focuses on expanding its global footprint through strategic partnerships, collaborations, and acquisitions. With its diversified portfolio and global operations, the company continues to deliver innovative healthcare solutions and contribute to the well-being of people worldwide.

What significant milestones has the company Shanghai Fosun Pharmaceutical Group Co achieved?

Shanghai Fosun Pharmaceutical Group Co Ltd has achieved several significant milestones in its history. The company has demonstrated consistent growth and expansion, becoming one of the leading pharmaceutical companies in China. It has successfully developed and marketed various innovative drugs, contributing to improved healthcare outcomes for patients. Shanghai Fosun Pharmaceutical Group Co Ltd has also made strategic acquisitions and formed partnerships to strengthen its market presence both domestically and internationally. Additionally, the company has received recognition for its commitment to research and development, as well as its contributions to healthcare philanthropy. These achievements make Shanghai Fosun Pharmaceutical Group Co Ltd a formidable player in the pharmaceutical industry.

What is the history and background of the company Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co Ltd, commonly known as Fosun Pharma, is a leading Chinese pharmaceutical company. Established in 1994, the company has a rich history and a strong background in the healthcare industry. Fosun Pharma focuses on research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medicines, and medical devices. Over the years, Fosun Pharma has expanded its presence globally and has become one of the largest comprehensive healthcare groups in China. With a commitment to innovation and high-quality products, Shanghai Fosun Pharmaceutical Group Co Ltd continues to make significant contributions to the advancement of healthcare worldwide.

Who are the main competitors of Shanghai Fosun Pharmaceutical Group Co in the market?

The main competitors of Shanghai Fosun Pharmaceutical Group Co Ltd in the market include multinational pharmaceutical companies such as Johnson & Johnson, Pfizer, Novartis, and GlaxoSmithKline. These competitors are well-established players in the global pharmaceutical industry and offer a wide range of products and services similar to Shanghai Fosun Pharmaceutical Group. As Shanghai Fosun Pharmaceutical Group aims to expand globally and capture a larger market share, it faces strong competition from these industry giants. However, Shanghai Fosun Pharmaceutical Group has its unique strengths, product portfolio, and innovative strategies to differentiate itself and gain a competitive advantage in the market.

In which industries is Shanghai Fosun Pharmaceutical Group Co primarily active?

Shanghai Fosun Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Shanghai Fosun Pharmaceutical Group Co?

The business model of Shanghai Fosun Pharmaceutical Group Co Ltd focuses on various aspects of the pharmaceutical industry. As a leading healthcare company, it engages in research and development, manufacturing, sales, and distribution of pharmaceutical products. Shanghai Fosun Pharmaceutical Group Co Ltd is committed to promoting innovation and improving the accessibility of healthcare products and services. It operates through segments such as pharmaceutical manufacturing, research and development, distribution and retail, and medical services. By leveraging its strong industry expertise and strategic partnerships, Shanghai Fosun Pharmaceutical Group Co Ltd aims to contribute to the advancement of healthcare and provide high-quality medical solutions to customers worldwide.

Shanghai Fosun Pharmaceutical Group Co 2024 की कौन सी KGV है?

Shanghai Fosun Pharmaceutical Group Co का केजीवी 21.01 है।

Shanghai Fosun Pharmaceutical Group Co 2024 की केयूवी क्या है?

Shanghai Fosun Pharmaceutical Group Co KUV 1.32 है।

Shanghai Fosun Pharmaceutical Group Co का AlleAktien गुणवत्ता स्कोर क्या है?

Shanghai Fosun Pharmaceutical Group Co के लिए AlleAktien गुणवत्ता स्कोर 4/10 है।

Shanghai Fosun Pharmaceutical Group Co 2024 का वार्षिक कारोबार कितना है?

अपेक्षित Shanghai Fosun Pharmaceutical Group Co का व्यापार वोल्यूम 44.88 अरब CNY है।

Shanghai Fosun Pharmaceutical Group Co 2024 का लाभ कितना है?

अपेक्षित Shanghai Fosun Pharmaceutical Group Co लाभ 2.82 अरब CNY है।

Shanghai Fosun Pharmaceutical Group Co क्या करता है?

The Shanghai Fosun Pharmaceutical Group Co Ltd is a leading company in the development, manufacturing, and marketing of pharmaceutical products and medical services. The business model is based on a diversified portfolio of business activities focused on various segments of the healthcare industry. The company's first division is the manufacturing of pharmaceutical products. Shanghai Fosun Pharma produces a wide range of medical products, including drugs, diagnostics, and medical devices. The company specializes in innovative drug manufacturing to offer high-quality medical solutions to its customers, with a strong emphasis on product quality. Another important division is research and development. Shanghai Fosun Pharma invests significantly in researching and developing new drugs and therapies. The company collaborates closely with international partners to develop innovative technologies and products that meet market needs. In addition to these activities, the company also operates hospitals, healthcare centers, and care facilities. Shanghai Fosun Pharma is a leading provider of high-quality healthcare services in China. The company strives to offer its customers a comprehensive range of services focused on the needs of patients. Furthermore, the group also has a subsidiary, Fosun Industrial Co Ltd, specializing in the manufacturing and marketing of chemicals and plastic products. This perfectly complements the company's portfolio and enables it to serve more customers. The company also offers various health products, including dietary supplements, medical aids, and wellness products. These products are sold in the company's own pharmacies as well as retail pharmacies nationwide. Shanghai Fosun Pharma also operates in overseas markets, with branches in various countries around the world. The company aims to bring product quality and innovation to the global market in order to make them accessible to an even larger part of society. In summary, the business model of Shanghai Fosun Pharmaceutical Group Co Ltd is based on innovation and differentiation through research and development, manufacturing, and distribution of drugs, medical services, and products. The company has a strong presence in the healthcare market and delivers world-leading products and services.

Shanghai Fosun Pharmaceutical Group Co डिविडेंड कितना है?

Shanghai Fosun Pharmaceutical Group Co एक वर्ष में बार वितरण करते हुए 0.56 CNY का डिविडेंड देता है।

Shanghai Fosun Pharmaceutical Group Co कितनी बार लाभांश देती है?

वर्तमान में Shanghai Fosun Pharmaceutical Group Co के लिए डिविडेंड की गणना नहीं की जा सकती है या फिर कंपनी डिविडेंड नहीं दे रही है।

Shanghai Fosun Pharmaceutical Group Co ISIN क्या है?

Shanghai Fosun Pharmaceutical Group Co का ISIN CNE000000X38 है।

Shanghai Fosun Pharmaceutical Group Co टिकर क्या है?

Shanghai Fosun Pharmaceutical Group Co का टिकर 600196.SS है।

Shanghai Fosun Pharmaceutical Group Co कितना लाभांश देती है?

पिछले 12 महीनों में Shanghai Fosun Pharmaceutical Group Co ने 0.42 CNY का डिविडेंड भुगतान किया। यह लगभग 1.89 % के डिविडेंड यील्ड के बराबर है। आगामी 12 महीनों के लिए Shanghai Fosun Pharmaceutical Group Co अनुमानतः 0.44 CNY का डिविडेंड भुगतान करेगी।

Shanghai Fosun Pharmaceutical Group Co का डिविडेंड यील्ड कितना है?

Shanghai Fosun Pharmaceutical Group Co का वर्तमान डिविडेंड यील्ड 1.89 % है।

Shanghai Fosun Pharmaceutical Group Co कब लाभांश देगी?

Shanghai Fosun Pharmaceutical Group Co तिमाही आधार पर लाभांश का भुगतान करता है। यह अगस्त, जुलाई, सितंबर, सितंबर महीनों में वितरित किया जाता है।

Shanghai Fosun Pharmaceutical Group Co का लाभांश कितना सुरक्षित है?

Shanghai Fosun Pharmaceutical Group Co ने पिछले 23 वर्षों में हर साल डिविडेंड का भुगतान किया।

Shanghai Fosun Pharmaceutical Group Co का लाभांश कितना है?

आने वाले 12 महीनों के लिए 0.44 CNY के डिविडेंड की उम्मीद की जा रही है। यह 2 % के डिविडेंड यील्ड के बराबर है।

Shanghai Fosun Pharmaceutical Group Co किस सेक्टर में है?

Shanghai Fosun Pharmaceutical Group Co को 'स्वास्थ्य' क्षेत्र से संबद्ध किया गया है।

Wann musste ich die Aktien von Shanghai Fosun Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

Shanghai Fosun Pharmaceutical Group Co का आखिरी लाभांश प्राप्त करने के लिए, जो 6/8/2024 को 0.27 CNY की राशि में था, आपको Ex-दिन 6/8/2024 से पहले इसे अपनी डिपो में रखना आवश्यक था।

Shanghai Fosun Pharmaceutical Group Co ने आखिरी बार लाभांश कब भुगतान किया था?

अंतिम लाभांश का भुगतान 6/8/2024 को किया गया था।

Shanghai Fosun Pharmaceutical Group Co का लाभांश 2023 में कितना था?

2023 में Shanghai Fosun Pharmaceutical Group Co द्वारा 0.56 CNY डिविडेंड के रूप में वितरित किए गए थे।

Shanghai Fosun Pharmaceutical Group Co डिविडेंड किस मुद्रा में वितरित करता है?

Shanghai Fosun Pharmaceutical Group Co के दिविडेंड CNY में वितरित किए जाते हैं।

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.03	0.33	0.18	0.34	0.37	0.63	1.24	0.69	0.75	0.99	1.08	1.01	1.31	3.56	3.13	5.2	3.11	3.73	4.13	6.05	7.47	9.16	9.99	11.93	13.58	16.94	15.33
0.05	0.05	0.1	0.12	0.17	0.24	0.3	0.39	0.46	0.48	0.45	0.45	0.56	0.84	0.93	0.91	1.29	1.5	1.74	1.97	3.25	3.62	4.37	4.57	6.03	7.59	7.79
0.08	0.05	0.03	0.09	0.13	0.14	0.22	0.11	0.12	0.27	0.22	0.35	0.23	0.42	0.66	0.76	0.76	0.69	0.62	0.8	1.28	1.42	1.58	1.81	2.01	1.55	1.91
0.05	0.05	0.1	0.08	0.12	0.36	0.31	0.47	0.53	0.61	0.5	0.53	0.6	0.93	1.12	1.27	1.61	1.61	1.65	1.67	2.75	3.29	3.94	5.16	5.47	6.88	7.54
0.01	0.03	0.06	0.03	0.26	0.05	0.03	0.1	0.1	0.07	0.27	0.08	0.61	0.16	0.22	0.24	0.21	1.14	0.19	0.29	0.31	0.5	0.53	1.61	3.33	2.32	1.23
0.22	0.51	0.47	0.66	1.05	1.41	2.1	1.76	1.96	2.42	2.52	2.42	3.31	5.91	6.05	8.38	6.99	8.67	8.33	10.77	15.06	18	20.4	25.09	30.42	35.28	33.79
0.04	0.07	0.2	0.24	0.35	0.57	0.78	1.05	1.24	1.26	1.14	1.15	1.26	1.69	2.63	3.57	5.06	5.84	5.92	6.39	8.41	9.37	11.43	13.26	14.44	17.4	23.67
0.02	0.05	0.21	0.58	0.77	1.03	1.18	2.12	2.24	2.59	3.47	3.68	6.66	8.18	10.24	10.05	11.61	14.41	17.23	18.85	21.12	24.06	23.02	23.77	23.92	25.55	25.01
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	189	77.4	212.8	282.07
0	0	0.02	0.03	0.04	0.1	0.1	0.18	0.2	0.21	0.21	0.2	0.21	0.53	1.71	1.78	2.64	2.91	3.25	3.65	8.28	9.19	10.97	11.5	13.43	15.93	17.38
0	0	0	0	0	0	0	0	0	0.05	0.05	0.05	0.05	0.34	1.59	1.66	2.98	3.26	3.3	3.47	8.46	8.85	9.01	8.68	9.4	10.34	10.85
0.01	0.01	0.02	0.02	0.01	0.04	0.05	0.03	0.03	0.06	0.05	0.04	0.04	0.18	0.08	0.06	0.21	0.26	0.18	0.64	0.64	1.07	1.29	1.21	1.59	2.47	2.48
0.07	0.13	0.44	0.87	1.17	1.74	2.1	3.39	3.71	4.18	4.92	5.12	8.22	10.92	16.24	17.13	22.49	26.67	29.88	33	46.92	52.55	55.72	58.6	62.87	71.88	79.68
0.29	0.64	0.92	1.53	2.22	3.15	4.21	5.15	5.67	6.59	7.44	7.54	11.53	16.83	22.29	25.51	29.47	35.34	38.2	43.77	61.97	70.55	76.12	83.69	93.29	107.16	113.47

0.06	0.15	0.23	0.29	0.29	0.38	0.38	0.83	0.83	0.95	1.24	1.24	1.24	1.9	1.9	2.24	2.24	2.31	2.31	2.42	2.5	2.56	2.56	2.56	2.56	2.67	2.67
0	0.3	0.22	0.67	0.73	0.69	0.72	0.76	0.82	1.48	1.49	1.06	1.16	1.83	2.21	4.29	6.28	6.15	6.06	7.86	9.08	10.55	12.14	15.13	14.03	16.99	16.85
0.05	0.06	0.16	0.15	0.25	0.4	0.59	0.71	0.74	0.61	1.14	1.71	4.08	4.69	5.67	7.04	5.63	7.12	8.93	11.12	13.37	15.15	17.65	20.23	23.87	26.17	27.5
0	0	0	0	0	0	0	0	-0	0	0	0	0	-0	-0.01	-0.01	1.18	1.12	0.92	0.83	0.4	-0.28	-0.47	-0.93	-1.38	-1.18	-1.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	113.9	-18.79	-236.87
0.1	0.51	0.6	1.11	1.27	1.47	1.69	2.29	2.39	3.05	3.87	4.01	6.48	8.42	9.77	13.56	15.33	16.7	18.23	22.22	25.34	27.98	31.89	37	39.19	44.64	45.73
0.05	0.04	0.07	0.07	0.09	0.32	0.32	0.41	0.47	0.41	0.27	0.36	0.46	0.73	0.76	0.78	0.99	0.83	0.97	1.03	1.65	2.18	2.15	2.94	4.52	5.43	5.51
0	0.01	0.01	0.01	0.01	0.04	0.04	0.07	0.06	0.09	0.05	0.08	0.07	0.11	0.21	0.31	0.48	0.59	0.61	0.75	0.88	1.03	0.98	1.13	1.51	1.89	2.33
0.08	0.03	0.07	0.11	0.13	0.2	0.32	0.28	0.3	0.26	0.25	0.28	0.35	0.93	1.66	1.3	2.24	3.09	1.94	2.06	3.47	4.03	5.14	5.22	6.41	7.3	5.33
0.02	0	0.06	0.13	0.63	0.78	0.48	0.75	0.87	1.45	1.46	0.98	1.11	1.88	1.78	1.15	1.53	3.91	5.55	4.45	9.85	5.76	6.6	8.66	11.75	13.27	15.84
0	0	0	0	0	0	0	0	0.01	0.14	0.18	0.06	0.5	0.06	0.59	0.36	0.04	1.11	1.86	1.82	0.76	4.93	2.56	6.92	5.13	5.41	4.75
0.15	0.07	0.22	0.32	0.86	1.34	1.17	1.51	1.71	2.34	2.22	1.76	2.5	3.7	4.99	3.89	5.28	9.54	10.94	10.11	16.6	17.92	17.43	24.87	29.31	33.3	33.76
0	0.03	0	0.03	0.03	0.05	1.02	0.75	0.98	0.55	0.75	1.18	1.29	2.76	3.92	4.28	4.2	3.88	3.59	5.58	9.82	12.69	12.99	9.34	9.9	13.04	15.89
0	0	0	0	0	0	0	0	0	0	0.07	0.08	0.7	0.87	1.6	1.36	1.78	1.93	1.85	1.79	2.98	2.91	2.99	2.85	3.13	3.36	3.45
0	0.01	0.01	0	0	0.01	0.01	0.11	0.1	0.1	0.09	0.08	0.09	0.1	0.42	0.67	0.55	0.89	1.16	1.04	2.83	3.44	3.5	0.64	2.57	3.36	3.76
0	0.04	0.01	0.03	0.03	0.05	1.03	0.86	1.09	0.64	0.9	1.34	2.08	3.72	5.93	6.31	6.53	6.7	6.59	8.41	15.63	19.04	19.48	12.83	15.61	19.76	23.1
0.15	0.12	0.23	0.35	0.88	1.39	2.2	2.37	2.79	2.98	3.12	3.09	4.58	7.42	10.92	10.2	11.81	16.23	17.53	18.52	32.23	36.96	36.92	37.7	44.92	53.05	56.85
0.26	0.63	0.84	1.46	2.16	2.86	3.89	4.66	5.19	6.03	6.99	7.1	11.05	15.84	20.69	23.76	27.14	32.93	35.76	40.74	57.57	64.94	68.81	74.7	84.11	97.69	102.58

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	2.34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	-188
66	-37	-52	-107	-150	-199	-308	-347	-341	-497	-470	-570	-535	-1,220	-2,103	-3,171	-3,721	-4,956	-5,976	-7,424	-11,359	-13,569	-12,871	-15,073	-18,041
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2,996	-572
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-14	-24	-14	-40	-65	-129	-239	-205	-185	-184	-209	-336	-363	-616	-755	-963	-1,171	-1,395	-1,560	-1,959	-2,410	-2,275	-2,196	-1,836	-1,609
0.07	0.04	0.14	0.07	0.1	0.15	0.21	0.19	0.18	0.13	0.23	0.26	0.2	0.32	0.67	1.01	1.2	1.62	2.11	2.58	2.95	3.22	2.58	3.95	4.22
-52	-78	-126	-141	-139	-264	-205	-222	-266	-209	-210	-348	-339	-796	-1,160	-1,040	-1,119	-1,235	-1,922	-2,170	-3,174	-3,962	-4,437	-4,972	-5,888
-99	-238	-443	-487	-150	162	-779	-437	-336	-53	56	-397	-264	-1,766	-978	-1,803	-2,478	-1,869	-2,447	-10,504	-5,244	-172	-4,706	-3,856	-4,064
-0.05	-0.16	-0.32	-0.35	-0.01	0.43	-0.57	-0.22	-0.07	0.16	0.27	-0.05	0.07	-0.97	0.18	-0.76	-1.36	-0.63	-0.53	-8.33	-2.07	3.79	-0.27	1.12	1.82
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.02	0.01	0.08	0.5	0.09	-0.29	0.16	0.35	0.8	0.38	-0.09	0.68	1.72	1.52	-0.46	-0.03	3.09	2	0.57	8.93	2.39	-2.44	2.25	1.81	3.75
372	77	435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.34	0.04	0.47	0.45	0.02	0.59	0.01	0.15	0.37	0.14	-0.35	0.4	1.82	0.91	2.07	-0.93	1.86	0.55	1.45	9.91	3.14	-1.94	1.47	-0.83	4.43
-0	-0.03	-0.04	0.04	0.02	0.98	0.01	0.03	-0	0.02	0.02	0.02	0.48	-0.06	3.23	0.15	-0.1	-0.34	2.07	2.41	4.3	2.37	1.05	-0.73	3.06
-7	-10	-4	-84	-91	-105	-149	-228	-428	-258	-277	-302	-378	-543	-707	-1,058	-1,126	-1,109	-1,193	-1,433	-3,551	-1,864	-1,834	-1,913	-2,374
0.32	-0.06	0.37	0.25	0.29	1.38	0.19	0.64	0.93	1.03	0.85	1.43	2.86	1.61	5.27	3.39	6.69	8.31	10.84	13.78	17.55	20.18	16.69	19.98	28.58
14.4	-39.8	11.8	-73.3	-37	-114	0.1	-34.3	-81.7	-78.2	22.4	-86.2	-135.8	-480.2	-495.1	-28.5	80.8	385.5	188	409.6	-224.8	-739.7	-1,857.3	-1,023.84	-1,671.27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

प्रत्यक्ष निर्गम	2,10,819
खरीदी गई ऊर्जा से संबंधित अप्रत्यक्ष उत्सर्जन	6,77,874
वर्तमान श्रृंखला में परोक्ष उत्सर्जन	72,171
CO₂ उत्सर्जन	8,88,693
CO₂-कमी रणनीति	✅
कोयला ऊर्जा	❌
परमाणु ऊर्जा	❌
प्रयोगशाला में जानवरों पर परीक्षण	✅
पेल्ज़ और लेदर	—
कीटनाशक	—
ताड़ का तेल	—
तंबाकू	❌
जेनेटिक इंजीनियरिंग	❌
क्लाइमाकॉन्ज़ेप्ट	—
स्थायी वानिकी	—
पुनर्चक्रण नियमन	✅
पर्यावरण के अनुकूल पैकेजिंग	✅
खतरनाक पदार्थ	✅
ईंधन खपत और दक्षता	✅
जल उपयोग और दक्षता	✅

महिला कर्मचारियों का प्रतिशत	49.529
प्रबंधन में महिलाओं की हिस्सेदारी	—
एशियाई कर्मचारियों की हिस्सेदारी	—
एशियाई प्रबंधन की हिस्सेदारी	—
हिस्पैनिक/लैटिनो कर्मचारियों का प्रतिशत	—
हिस्पैनो/लैटिनो प्रबंधन हिस्सा	—
श्वेत अधिकारियों का प्रतिशत	—
काले प्रबंधन की हिस्सेदारी	—
श्वेत कर्मचारियों का अनुपात	—
श्वेत प्रबंधन में हिस्सेदारी	—
वयस्क सामग्री	❌
अल्कोहल	❌
रक्षा	—
शस्त्र	❌
जुआ	❌
सैन्य अनुबंध	❌
मानवाधिकार अवधारणा	✅
गोपनीयता नीतи	—
काम और स्वास्थ्य सुरक्षा	✅
कैथोलिक	✅

स्थिरता रिपोर्ट	✅
स्टेकहोल्डर-इंगेजमेंट	✅
नीतियाँ वापस बुलाने की	❌
प्रतिस्पर्धा कानून	❌

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.19	0.34	0.49	0.57	0.73	1.03	2.16	2.43	2.99	4.08	3.69	3.77	3.87	4.56	6.49	7.34	10	12.03	12.61	14.63	18.53	24.92	28.59	30.31	39.01	43.95	41.4	44.88	48.53	51.85
-	78.95	43.24	16.43	28.40	41.76	108.82	12.53	23.26	36.57	-9.53	2.17	2.62	17.64	42.39	13.18	36.17	20.31	4.85	16.02	26.69	34.44	14.72	6.02	28.70	12.68	-5.81	8.42	8.12	6.83
36.84	37.06	42.71	43.56	37.23	34.40	26.91	31.22	29.98	21.34	26.59	27.67	32.02	33.90	37.63	43.62	44.22	43.87	49.78	53.81	58.84	58.34	59.57	55.47	47.97	47.09	47.54	-	-	-
0.07	0.13	0.21	0.25	0.27	0.36	0.58	0.76	0.9	0.87	0.98	1.04	1.24	1.54	2.44	3.2	4.42	5.28	6.28	7.87	10.91	14.54	17.03	16.81	18.71	20.7	19.68	0	0	0
0.05	0.07	0.11	0.1	0.08	0.07	0.06	0.15	0.14	0.09	0.16	0.12	0.16	0.16	0.32	0.55	1.03	1.11	1.36	1.64	2.24	2.29	2.49	2.64	2.55	3.5	1.29	2.26	2.63	2.79
27.37	20.88	21.77	17.11	10.44	6.88	2.92	6.31	4.78	2.25	4.44	3.13	4.05	3.58	5.00	7.53	10.30	9.19	10.81	11.23	12.06	9.17	8.71	8.72	6.54	7.97	3.10	5.04	5.42	5.37
0.04	0.06	0.09	0.1	0.14	0.15	0.26	0.22	0.16	0.26	0.63	0.69	2.5	0.86	1.17	1.56	1.58	2.11	2.46	2.81	3.12	2.71	3.32	3.66	4.74	3.73	2.39	2.82	3.32	3.78
-	55.00	50.00	10.75	38.83	2.80	76.19	-16.99	-26.05	62.26	142.64	10.38	261.51	-65.41	34.95	34.13	1.21	33.48	16.42	14.07	11.33	-13.32	22.67	10.26	29.27	-21.22	-36.03	18.32	17.64	13.88
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.55	1.42	1.42	1.49	1.49	1.49	1.49	1.61	1.62	1.86	1.86	1.86	1.86	1.89	1.9	2.24	2.24	2.3	2.32	2.33	2.46	2.52	2.56	2.56	2.56	2.61	2.67	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Shanghai Fosun Pharmaceutical Group Co टिकर	Shanghai Fosun Pharmaceutical Group Co FIGI
600196:CH	BBG000C4SR52
600196:CG	BBG000C4SRF1
600196:C1	BBG00709HHX2

अपने जीवन के सर्वश्रेष्ठ निवेश करें fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

शेयर मूल्य

शेयर मूल्य

टिकर600196.SS

ISINCNE000000X38

Shanghai Fosun Pharmaceutical Group Co शेयर कीमत

कुर्स

अवलोकन

इंट्राडे सुविधा

कुल रिटर्न और सापेक्षिक मूल्य परिवर्तन

व्याख्या और निवेश

Shanghai Fosun Pharmaceutical Group Co शेयर मूल्य इतिहास

Shanghai Fosun Pharmaceutical Group Co शेयर बिक्री, EBIT, लाभ CNE000000X38 ·

उमसात्ज, गेविन्न & EBIT

उमसात्ज, EBIT और आय की समझ

सालाना विश्लेषण और तुलनाएँ

निवेश के लिए उम्मीदें उपयोग करें

निवेश संविधान

Shanghai Fosun Pharmaceutical Group Co बिक्री, लाभ और ईबीआईटी इतिहास

Shanghai Fosun Pharmaceutical Group Co शेयर मापदंड

गुआव

आय और विकास

सकल मार्जिन

EBIT और EBIT-मार्जिन

आय और विकास

शेयर बकाया

वार्षिक तुलना की व्याख्या

अपेक्षाएँ और अनुमान

बिलान्ज

बिलान्ज की समझ

संपत्तियाँ

दायित्व

मालिकाना हक

वर्ष-दर-वर्ष विश्लेषण

डेटा की व्याख्या

Shanghai Fosun Pharmaceutical Group Co शेयर मार्जिन CNE000000X38 ·

मार्जिन

ब्रूटोमार्जिन की समझ

EBIT मार्जिन विश्लेषण

उम्सात्झ्मार्जिन अंतर्दृष्टि

अपेक्षाओं की व्याख्या

तुलनात्मक विश्लेषण

Shanghai Fosun Pharmaceutical Group Co मार्जिन इतिहास

Shanghai Fosun Pharmaceutical Group Co शेयर बिक्री, EBIT, प्रति शेयर लाभ CNE000000X38 ·

उमसत्ज़, EBIT और प्रति शेयर लाभ

प्रति शेयर उमसत्ज़

प्रति शेयर EBIT

प्रति शेयर आय

अनुमानित मान

Shanghai Fosun Pharmaceutical Group Co बिक्री, लाभ और EBIT प्रति शेयर इतिहास

Shanghai Fosun Pharmaceutical Group Co शेयर और शेयर विश्लेषण

Shanghai Fosun Pharmaceutical Group Co Fair Value के अनुसार मूल्यांकन

Fair Value

Fair Value की समझ

आय-आधारित Fair Value

राजस्व-आधारित Fair Value

लाभांश-आधारित Fair Value

अपेक्षाएँ और अनुमान

तुलनात्मक विश्लेषण

Shanghai Fosun Pharmaceutical Group Co का मूल्यांकन ऐतिहासिक P/E अनुपात, EBIT और P/S अनुपात के अनुसार

Shanghai Fosun Pharmaceutical Group Co संख्या शेयर CNE000000X38 ·

उमसत्ज़, EBIT और प्रति शेयर लाभ

प्रति शेयर उमसत्ज़

प्रति शेयर EBIT

प्रति शेयर आय

अनुमानित मान

Shanghai Fosun Pharmaceutical Group Co एक्टियन्स्प्लिट्स

Shanghai Fosun Pharmaceutical Group Co शेयर लाभांश CNE000000X38 ·

डिविडेंड

डिविडेंड संबंधी समीक्षा

व्याख्या और प्रयोग

निवेश रणनीति

Shanghai Fosun Pharmaceutical Group Co डिविडेंड इतिहास

Shanghai Fosun Pharmaceutical Group Co शेयर वितरण अनुपात CNE000000X38 ·

वितरण अनुपात

वार्षिक वितरण अनुपात क्या है?

डेटा की व्याख्या कैसे करें

निवेश के लिए डेटा का उपयोग

Shanghai Fosun Pharmaceutical Group Co वितरण अनुपात इतिहास

Shanghai Fosun Pharmaceutical Group Co आय अनुमान

अपने जीवन के सर्वश्रेष्ठ निवेश करें
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

टिकर
600196.SS

ISIN
CNE000000X38